ROLKE JAMES (Chief Executive Officer) received a stock award from REVELATION BIOSCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/18/2026ACC: 0001193125-26-355663
DirectorOfficer· Chief Executive Officer
Since Jan 2022
+208.08K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
208.08K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+208.08K
Price / share
—
Trade value
—
% of position
96.9%
8/17/2026
214.74K→422.81K
Total
Net shares
+208.08K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2026 | A · Award | +208.08K | — | — | 96.9% | 214.74K | 422.81K |
| Total | +208.08K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported